Inaktiver Wert

Andere Sprachen BioPharmX Corp OTC Bulletin Board

Aktien

US09072X1019

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

04.04.	Erster Antrag auf Verlängerung der Exklusivitätsfrist für Timber Pharmaceuticals, Inc. bewilligt	CI
20.03.	Zweite revidierte Offenlegungserklärung und Plan für Timber Pharmaceuticals, Inc. vorläufig genehmigt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc.	06.05.
First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.	04.04.
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.	20.03.
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc.	15.03.
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting	10.03.
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc.	27.02.
LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals	24.01.
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.	22.01.
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q).	22.01.
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc.	05.01.
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc.	05.01.
Bidding Procedure Approved for Timber Pharmaceuticals, Inc.	15.12.
Final DIP Financing Approved for Timber Pharmaceuticals, Inc.	15.12.
Timber Pharmaceuticals to Be Delisted From NYSE American	29.11.
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market	29.11.
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations	29.11.
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American	28.11.
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index	24.11.
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc.	22.11.
Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.	21.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioPharmX Corp OTC Bulletin Board

Aktien

US09072X1019

Andere Sprachen

Filter